期刊文献+

hTR反义寡核苷酸对不同鼻咽癌细胞生长分化的影响 被引量:1

Effects of telomerase antisense oligodeoxynucleotides on growth and differentiation of nasopharyngeal carcinoma cells
下载PDF
导出
摘要 目的 :研究端粒酶反义寡核苷酸对鼻咽癌细胞生长分化的影响。方法 :脂质体介导反义寡核苷酸转染鼻咽癌CNE1和CNE2Z细胞株 ,用细胞体外增殖实验、免疫组织化学S P法 ,观察细胞生长分化的变化情况。结果 :针对端粒酶RNA模板区的反义寡核苷酸可抑制CNE1和CNE2Z细胞的增殖并呈剂量和时间依赖性 ,反义寡核苷酸组细胞角蛋白表达高于其它处理组及空白对照组 (P <0 0 1) ,细胞形态趋向分化成熟。结论 :端粒酶反义寡核苷酸可抑制鼻咽癌CNE1和CNE2Z细胞的生长 ,并促进细胞分化。 Purpose To study the effects of telomerase antisense oligodeoxynucleotides (ASODN) on CNE1 and CNE2Z cell lines of nasopharyngeal carcinoma cells (NPC). Methods After transfecting telomerase ASODN into NPC CNE1 and CNE2Z cell lines by lipoffectin, the proliferation, morphological changes and keratin expression of the cells were studied. Results ASODN targeted at telomerase RNA template sequence acted as a specific growth inhibitor to CNE1 and CNE2Z cell lines, and presented in a dose and time dependent manner. At the same time, the morphology of the cells also changed obviously, and the keratin expression of ASODN group was significantly higher than that of the other treatment groups and control group ( P <0 01). Conclusion Telomerase ASODN is able to inhibit the growth of CNE1 and CNE2Z cell lines of NPC, and induce the cell differentiation into morphologically mature.
出处 《临床与实验病理学杂志》 CAS CSCD 2002年第4期397-400,共4页 Chinese Journal of Clinical and Experimental Pathology
关键词 HTR 反义寡核苷酸 鼻咽癌 细胞生长分化 nasopharyngeal neoplasms oligonucleotides, antisense differentiation
  • 相关文献

参考文献2

二级参考文献14

  • 1[7]Bhattachryya A, Blackburn EH. A functional telomerase RNA swap in vivo reveals the importance of non template RNA domain. Proc Natl Acad Sci USA, 1997;94: 2823~7
  • 2[8]Hiyama T, Yokozaki H, Kitadai Y et al. In situ mRNA hybridization technique for analysis of human telomerase RNA in gastric precancerous and cancerous lesions. Jpn J Cancer Res, 1998;89: 1187~94
  • 3[9]Rushing EJ, Yashima K, Brown DF et al. Expression of telomerase RNA component correlates with the MIB-1 proliferation index in Ependymomas. J Neuropathol Exp Neurol, 1997;56: 1142~6
  • 4[10]Blasco MA, Rizen M, Greider CW et al. Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nat Genet, 1996;12: 200~4
  • 5[11]Avillion AA, Piatyszek A, Gupta J et al. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res, 1996;56: 645~50
  • 6[1]Moniku E, Pamela D, Jose G et al. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer. Clin Cancer Res, 1997;3: 1931~41
  • 7[2]Soder AI, Hoare SF, Muir S et al. Amplification, increased dosage and in situ expression of the telomerase RNA gene in human cancer. Oncogene, 1997;14: 1013~21
  • 8[3]Loveday RL, Greenman J, Drew PJ et al. Genetic changes associated with telomerase activity in breast cancer. Int J Cancer, 1999;84: 516~20
  • 9[4]Yashima K, Piatyszak MA, Saboorian HM et al. Telomerase activity and in situ telomerase RNA expression in malignant and non-malignant lymph nodes. J Clin Pathol, 1997;50: 110~7
  • 10[5]Greider CW. Telomerase activity, cell proliferation and cancer. Proc Natl Acad Sci USA, 1998;95(1): 90~2

共引文献6

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部